InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,700.00
(
-0.02%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
78.70
(
0.00%
)
Bitcoin
63,028.42
(
0.92%
)
Post# of 82595
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ann441j

Send PM Follow Ignore
Followers 6
Posts 3891
Boards Moderated 0
Alias Born 01/14/2001

ann441j

Member Level

Re: None

Friday, 08/11/2006 2:59:17 AM

Friday, August 11, 2006 2:59:17 AM

Post# of 82595
Super EPO progress:

"DNAPrint Pharmaceuticals Completes Development, Validation On Second Assay For Investigational Anemia Drug
8/7/2006

Source: VerusMed

KBI BioPharma Inc. has completed and validated a second analytical method for PT-401, an anemia drug. The method is based on SDS-PAGE, a well-established separation technique that will be used for in-process analysis, release and stability testing of PT-401, which is being developed by DNAPrint Pharmaceuticals Inc., a subsidiary of DNAPrint Genomics Inc.

Ann

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM

CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM

Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM

Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM

Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM

BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!